Tranexamic Acid for Hemoptysis: Nebulization vs IV

This study is exploring the best way to give tranexamic acid, a medication used to control bleeding, to people experiencing hemoptysis, which is coughing up blood. The study focuses on two methods of delivering the medication: through a nebulizer, which turns the medicine into a mist to be inhaled, and through an intravenous (IV) route, which is delivered directly into the bloodstream. The goal is to determine which method is more effective in stopping the bleeding quickly and preventing it from coming back. This research is important because finding the most efficient way to manage hemoptysis can improve patient outcomes and treatment experiences. Participants in the study will be randomly assigned to one of two groups. One group will receive tranexamic acid through a nebulizer, while the other group will receive it via an IV. The study will track how long it takes for the bleeding to stop completely after each treatment and how soon it might return. Another important measure is the reduction in the amount of blood found in the sputum, or the mucus coughed up from the lungs, after each form of treatment. By comparing these outcomes, researchers aim to identify any potential benefits or risks associated with each delivery method.